Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice

Anita M. Hoek, Elsbet J. Pieterman, José W. Hoorn, Marta Iruarrizaga‐Lejarreta, Cristina Alonso, Lars Verschuren, Tore Skjæret, Hans M.G. Princen, David A. Fraser – 24 December 2019 – Icosabutate is a structurally engineered eicosapentaenoic acid derivative under development for nonalcoholic steatohepatitis (NASH).

Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts

Ayako Sato, Sei Kakinuma, Masato Miyoshi, Akihide Kamiya, Tomoyuki Tsunoda, Shun Kaneko, Jun Tsuchiya, Taro Shimizu, Eiko Takeichi, Sayuri Nitta, Fukiko Kawai‐Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe – 24 December 2019 – Formation of intrahepatic bile ducts (IHBDs) proceeds in accordance with their microenvironment.

Model for End‐Stage Liver Disease With Additional Criteria to Predict Short‐Term Mortality in Severe Flares of Chronic Hepatitis B

James Fung, Lung‐Yi Mak, Albert Chi‐Yan Chan, Kenneth Siu‐Ho Chok, Tiffany Cho‐Lam Wong, Tan‐To Cheung, Wing‐Chiu Dai, Sui‐Ling Sin, Wong‐Hoi She, Ka‐Wing Ma, Wai‐Kay Seto, Ching‐Lung Lai, Chung‐Mau Lo, Man‐Fung Yuen – 23 December 2019

Subscribe to